Derived Trail Making test indices in a sample of sedative abusers: Demographic effects

International Journal of Neuroscience

Volumn 112, Issue 8, 2002, Pages 985-994

  Roberts, Charles ^a   Horton Jr , Arthur MacNeill ^a  

^a Substance Abuse Mental Hlth S   (United States)

Author keywords

Derived indices; Sedatives; Substance abuse treatment; Trail making test

Indexed keywords

HYPNOTIC SEDATIVE AGENT;

ADDICTION; ADOLESCENT; ADULT; AGE; ARTICLE; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOMOTOR PERFORMANCE; RACE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; COGNITION DISORDERS; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TRAIL MAKING TEST;

EID: 0036690780     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450290025987     Document Type: Article

References (37)

1. Bias in a neuropsychological test classification related to education, age, and ethnicity
2. Neuropsychological deficit, ethnicity, and socioeconomic status
3. Analysis of certain psychological tests used for the evaluation of brain damage
4. Dependence on sedative hypnotics: Neuropsychological impairment, field dependence, and clinical course in a 5-year follow-up study
5. Neuropsychological impairment and the exclusive abuse of sedative or hypnotics
6. Neuropsychological test usage
7. Neuropsychological assessment of African Americans: Conceptual and methodological considerations
8. Relationships between parts A and B of the Trail Making Test
9. The influence of age on the Trail Making Test performance
10. Treatment structure and program services in the Drug Abuse Treatment Outcome Study
11. Drug Abuse Treatment Outcome Study (DATOS): Treatment evaluation research in the United States
12. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS)
13. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis
14. A comparison of cognitive impairment due to benzodiazepines and to narcotics
15. Some suggestions regarding the clinical interpretation of the Trail Making Test
16. Future directions in the development of addiction assessment instruments
17. Neuropsychology of drug abuse
18. Derived Trail Making Test Indices in a sample of heroin abusers: Demographic effects
19. Derived Trail Making Test Indices in a sample of hallucinogen abusers: Demographic effects
20. Brain dysfunction in chronic sedative users
21. Derived Trail Making Test indices: A preliminary report
22. A comparison of the Trail Making Test, Symbol Digit Modalities Test and the Hooper Visual Organization Test in an inpatient substance abuse population
23. Efficient screening for brain-dysfunction
24. Neuropsychological assessment of substance abusers: Review and recommendations
25. The Trail Making Test and Bender background interference procedure as screening devices
26. The relation of the Trail Making Test to organic brain damage
27. Validity of the Trail Making Test as an indicator of organic brain damage
28. Derived Trail Making Test Indices in a sample of alcohol abusers: Demographic effects
29. Derived Trail Making Test Indices in a sample of amphetamine abusers: Demographic effects
30. Trail Making Test: Issues in normative data selection